This Award Notice opportunity from Department Of Health And Human Services was posted on July 17, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Analytical Services Center for Medications Development Program
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
On July 17, 2022, the National Institute on Drug Abuse under the Department of Health and Human Services awarded Contract No. 75N98026D00031 to MRIGlobal to establish and operate the Analytical Services Center for Medications Development. This award, made in response to Solicitation 75N95024R00032, is not a request for quotes or proposals but a formal notice of contract issuance. The contract will be executed over a five-year period through the issuance of task orders and will utilize a hybrid funding structure combining Cost Plus Fixed Fee and Firm Fixed Price mechanisms to support the full scope of analytical services required. The primary place of performance is in Bethesda, Maryland, with all activities centered around advancing medications development through rigorous analytical support. The contract is managed by the National Institutes of Health’s NIDA office located at 9800 Medical Center Drive, Bethesda, MD, 20892. Primary point of contact is Shaun Rostad, reachable at [phone hidden] or [email hidden], with secondary support provided by Josh Lazarus at [phone hidden] or [email hidden]. The North American Industry Classification System code for this contract is 541715, indicating the nature of the work as research and development in the physical, engineering, and life sciences. The contract was posted on SAM.gov on July 17, 2026, and all performance, reporting, and administrative functions are to be conducted in alignment with federal acquisition regulations and NIDA-specific program objectives.
General Info
Contract End Date
July 20, 2026Documents
0No documents available
This contract was awarded without public documents.
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
This one is closed. Find the next one like it.
Open contracts like this one, right now:
- Research and Technical Analysis for Test SystemsOpen now, due in 17 days
- Altermagnetic Material CharacterizationOpen now, due in 21 days
Ask CLEATUS
I've read this contract. Ask me anything.
Timeline
Award Notice
Contract was awarded
Organization & Contact Information
Full Description
NOTICE OF AWARD. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS.
On July 17, 2022; in response to the requirements of Solicitation 75N95024R00032, the National Institute on Drug Abuse (NIDA) awarded Contract No. 75N98026D00031 to MRIGlobal for the Analytical Services Center for Medications Development . NIDA anticipates the use of Task Orders with an ultimate Period of Performance of five (5) years. An award shall be made on a Cost Plus Fixed Fee and Firm Fixed Price basis.
More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Get AI-powered intelligence on the opportunities still open
Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.
Join 750+ contractors already using CLEATUS
